Clinical Trials Directory

Trials / Completed

CompletedNCT00486525

Hatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Breast Cancer Survivors

Breast Cancer Survivors: Physical Activity, Inflammation, Fatigue, and Distress

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
Female
Age
21 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Yoga may improve inflammation, fatigue, and depression in female breast cancer survivors. PURPOSE: This randomized clinical trial is studying how well Hatha yoga works in improving physical activity, inflammation, fatigue, and distress in female breast cancer survivors.

Detailed description

OBJECTIVES: Primary * To determine if the yoga intervention will decrease inflammation, fatigue, and depressive symptoms relative to the waiting-list controls in women who are stage 0-IIIa breast cancer survivors. OUTLINE: Patients are stratified according to stage of cancer (stage 0 vs stage I vs stage II and stage IIIA) and prior radiation therapy (yes vs no). Patients are randomized to 1 of 2 intervention arms. * Arm I (waiting-list control): Patients are encouraged to perform usual activities, but asked to refrain from any yoga practice or other related activities. After a six-month observation period, patients undergo yoga intervention as described in arm II . * Arm II (yoga intervention): Patients participate in a Hatha yoga intervention session comprising body postures and breath control techniques for 1.5 hours twice a week for 12 weeks. Patients are encouraged to practice Hatha yoga at home. Patients complete daily diaries on home Hatha yoga practices and submit them at each session.

Conditions

Interventions

TypeNameDescription
PROCEDUREYoga TherapyPatients will undergo yoga therapy

Timeline

Start date
2007-08-01
Primary completion
2012-11-01
Completion
2013-03-01
First posted
2007-06-14
Last updated
2014-05-05
Results posted
2014-04-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00486525. Inclusion in this directory is not an endorsement.